Zobrazeno 1 - 10
of 42
pro vyhledávání: '"YECHEN XIAO"'
Autor:
Chengyu Lv, Yuqiu Li, Rong Liang, Wei Huang, Yechen Xiao, Xinqi Ma, Yongjun Wang, Haoyang Zou, Fen Qin, Chang Sun, Tiezhu Li, Jie Zhang
Publikováno v:
Current Research in Food Science, Vol 6, Iss , Pp 100459- (2023)
Numerous studies have reported that tangeretin is a polymethoxylated flavone with a variety of biological activates, but little research has been done on the antioxidant mechanism of tangeretin. Hence, we investigated the effect of tangeretin on the
Externí odkaz:
https://doaj.org/article/7e46dcde151e4402b145129b625e27d3
Autor:
Zhong Zheng, Haotian Ji, Wenbo Zong, Qiuju Ran, Xinxin Wang, Xi Yang, Zhuo Zhao, Chengjun Yang, Yechen Xiao
Publikováno v:
AMB Express, Vol 9, Iss 1, Pp 1-9 (2019)
Abstract Fibroblast growth factor receptor 3 (FGFR3) plays an important regulatory role in tumor cell proliferation and drug resistance. FGFR3 is often constitutively active in many tumors. To deliver drugs into tumor cells by targeting FGFR3 will be
Externí odkaz:
https://doaj.org/article/cb97c3b2ca17418b8acb5d61ac968007
Autor:
Chen Guo, Qiuju Ran, Chun Sun, Tingting Zhou, Xi Yang, Jizhou Zhang, Shifeng Pang, Yechen Xiao
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2021)
Chemotherapeutic patients with leukemia often relapse and produce drug resistance due to the existence of leukemia stem cells (LSCs). Fibroblast growth factor receptor 3 (FGFR3) signaling mediates the drug resistance of LSCs in chronic myeloid leukem
Externí odkaz:
https://doaj.org/article/195afa51c2a145daab2b7130e86a4699
Publikováno v:
Electronic Journal of Biotechnology, Vol 28, Iss C, Pp 14-19 (2017)
Background: Gain-of-function of fibroblast growth factor receptor 3 (FGFR3) is involved in the pathogenesis of many tumors. More and more studies have focused on the potential usage of therapeutic single-chain Fv (ScFv) antibodies against FGFR3. RNA
Externí odkaz:
https://doaj.org/article/629b83583b0841a8a2207440c7ed20ed
Autor:
Zixuan Liu, Jizhou Zhang, Hongqiong Fan, Ruofeng Yin, Zhong Zheng, Qian Xu, Qing Liu, Haiting He, Xiaofan Peng, XinXin Wang, Xiaokun Li, Yechen Xiao
Publikováno v:
Electronic Journal of Biotechnology, Vol 18, Iss 4, Pp 302-306 (2015)
Background: Overexpression or mutated activation of Fibroblast growth factor receptor 3 (FGFR3) is involved in the pathogenesis of many tumors. More and more studies focus on the potential usage of therapeutic antibodies against FGFR3. Results: In th
Externí odkaz:
https://doaj.org/article/e7f6541cc8894bb185f5806e7155e8d7
Autor:
Xinqi Ma, Yuqiu Li, Chengyu Lv, Bin Liu, Cuiping Yuan, Wei Huang, Quan Luo, Yechen Xiao, Chang Sun, Tiezhu Li, Jie Zhang
Publikováno v:
Food Bioscience. 50:102162
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3570dc9107145ca750afd482b887c271
https://doi.org/10.1016/j.fbio.2022.102162
https://doi.org/10.1016/j.fbio.2022.102162
Publikováno v:
Transplantation and cellular therapy. 27(1)
Patients with chemotherapy or radiation therapy often generate anemia and low immunity due to the therapy-induced bone marrow (BM) suppression. To enhance hematopoietic regeneration during the therapy-induced BM suppression urgently need to be solved
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6682a7ec25d8bf6fc0273719c52f25d4
https://pubmed.ncbi.nlm.nih.gov/32966879
https://pubmed.ncbi.nlm.nih.gov/32966879
Publikováno v:
Life Sciences. 182:80-84
ADP-ribosylation factor 6 (Arf6), a member of small GTPases ADP-ribosylation factor (Arf) family, expresses widely in mammalian cells and mainly regulates the functions of membrane traffic and actin remodeling. Current studies indicated that the acti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd74f1b64db5684754ed297c3824acae
https://doi.org/10.1016/j.lfs.2017.06.008
https://doi.org/10.1016/j.lfs.2017.06.008
Publikováno v:
Electronic Journal of Biotechnology, Vol 28, Iss C, Pp 14-19 (2017)
Normal 0 false false false EN-US X-NONE X-NONE Background : Gain-of-function of fibroblast growth factor receptor 3 (FGFR3) is involved in the pathogenesis of many tumors. More and more studies have focused on the potential usage of therapeutic singl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78e32e14f066a4d406fc424342d212fa
https://doi.org/10.1016/j.ejbt.2017.05.009
https://doi.org/10.1016/j.ejbt.2017.05.009
Autor:
Haotian Ji, Chengjun Yang, Zhong Zheng, Wenbo Zong, Xinxin Wang, Zhuo Zhao, Xi Yang, Yechen Xiao, Qiuju Ran
Publikováno v:
AMB Express
AMB Express, Vol 9, Iss 1, Pp 1-9 (2019)
AMB Express, Vol 9, Iss 1, Pp 1-9 (2019)
Fibroblast growth factor receptor 3 (FGFR3) plays an important regulatory role in tumor cell proliferation and drug resistance. FGFR3 is often constitutively active in many tumors. To deliver drugs into tumor cells by targeting FGFR3 will be a promis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c036f1dc5c377ca8a6dc9792583653c4
http://europepmc.org/articles/PMC6751232
http://europepmc.org/articles/PMC6751232